×
About 358 results

ALLMedicine™ Kallmann Syndrome Center

Research & Reviews  141 results

Two females presenting primary amenorrhea diagnosed with Kallmann syndrome caused by no...
https://doi.org/10.1111/jog.14966
The Journal of Obstetrics and Gynaecology Research; Xia J, Luo X et. al.

Aug 4th, 2021 - Primary amenorrhea as the common symptom has a complicated etiology, and genetic disorders are non-negligible. Kallmann syndrome (KS) is a rare inherited disease characterized by hypogonadotropic hypogonadism and anosmia. KS is uncommon in women a...

Kallmann syndrome and idiopathic hypogonadotropic hypogonadism: The role of semaphorin ...
https://doi.org/10.1016/B978-0-12-819973-2.00022-8
Handbook of Clinical Neurology; Cariboni A, Balasubramanian R

Jul 17th, 2021 - Idiopathic hypogonadotropic hypogonadism and Kallmann syndrome are rare genetic disorders characterized by isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) and delayed or absent puberty. Defective GnRH neuron migration during develo...

A Novel Noncanonical Splicing Mutation of ANOS1 Gene in Siblings with Kallmann Syndrome...
https://doi.org/10.1007/s43032-021-00672-6 10.1016/j.fertnstert.2018.09.012 10.1016/S2213-8587(16)30043-2 10.1038/353529a0 10.1016/j.gene.2019.144177 10.1038/nrendo.2015.112 10.1016/j.metabol.2017.10.012 10.1210/jc.2005-2793 10.1016/0378-1119(94)90567-3 10.1073/pnas.1101135108
Reproductive Sciences (Thousand Oaks, Calif.); Xia Y, Guo H et. al.

Jul 8th, 2021 - Kallmann syndrome (KS) is a rare genetic disorder that is characterized by idiopathic hypogonadotropic hypogonadism associated with anosmia. Genetic variants in ANOS1 gene are the most common mutations associated with X-linked recessive form of KS...

Advances in Genetic Diagnosis of Kallmann Syndrome and Genetic Interruption.
https://doi.org/10.1007/s43032-021-00638-8 10.1186/1750-1172-6-41 10.1210/er.2015-1045.2016.110.1210/er.2015-1045.2016.1.test 10.1210/jcem.81.12.8954047 10.1007/s00018-005-5604-3 10.1038/ejhg.2008.206 10.1523/JNEUROSCI.0867-10.2010 10.1016/j.stem.2008.03.005 10.1523/JNEUROSCI.6087-10.2011 10.1038/232496a0 10.1210/er.2009-0023 10.1038/338161a0 10.1073/pnas.86.20.8132 10.1002/(SICI)1096-9861(19960311)366:3<547::AID-CNE12>3.0.CO;2-M 10.1242/dev.139444 10.1016/0169-328x(89)90076-4 10.1016/S2213-8587(15)00418-0 10.1097/MED.0000000000000339 10.1016/s0022-3476(75)80969-3 10.1016/s0022-3476(99)70244-1 10.1038/nrendo.2015.112 10.3109/00016349409006255 10.1212/wnl.52.4.816 10.1111/j.1365-263X.2010.01056.x 10.1597/1545-1569_1997_034_0417_cmipwk_2.3.co_2 10.1210/jc.2012-4116 10.1507/endocrj.ej12-0134 10.1210/er.2018-00116 10.2500/ajr.2007.21.3043 10.1210/jc.2011-2041 10.1210/jc.2004-2465 10.3174/ajnr.A3946 10.1016/j.ando.2016.12.003 10.1038/353529a0 10.6061/clinics/2013(sup01)06 10.1002/(SICI)1097-0177(199905)215:1<26::AID-DVDY4>3.0.CO;2-D 10.1038/nrendo.2009.177 10.1210/jcem.82.1.3692 10.1093/molehr/gan027 10.1530/EJE-17-0335 10.1016/s0092-8674(00)00100-8 10.1038/ng1122 10.1159/000312693 10.1073/pnas.0600962103 10.1210/jc.2004-1361 10.4274/jcrpe.2017.S010 10.1016/s0925-4773(00)00518-9 10.1210/jc.2003-030476 10.1111/j.1460-9568.2007.05958.x 10.1371/journal.pgen.0020175 10.1126/science.1112103 10.1073/pnas.0508881103 10.1210/jc.2008-0958 10.1038/ng1407 10.1111/j.1399-0004.2008.01107.x 10.1016/j.ajhg.2008.09.005 10.1210/jc.2014-2110 10.1530/EJE-17-0749 10.1126/science.8202715 10.1038/gim.2017.197 10.6065/apem.2018.23.2.57 10.1056/NEJMcp1109290 10.1046/j.1365-2265.2001.01277.x 10.1056/NEJM199702063360604 10.1210/jc.2010-0245 10.1016/j.metabol.2017.10.012 10.1186/1750-1172-1-34 10.1159/000438841 10.1136/jmg.2010.087106 10.3109/09513590.2012.752459 10.1210/jc.2013-2809 10.1056/NEJMoa066494 10.1016/j.ogc.2017.02.004 10.1002/pd.1970120104 10.1016/j.beem.2014.10.005 10.5603/GP.2016.0037 10.1007/s11427-014-4683-5 10.1126/science.1229164 10.1073/pnas.1523297113 10.1016/j.jgg.2016.03.011 10.1007/s10815-017-1018-z 10.1080/19396368.2019.1590479 10.1016/j.jgg.2019.04.003 10.1007/s10815-019-01434-9 10.1007/s10815-019-01604-9
Reproductive Sciences (Thousand Oaks, Calif.); Liu Y, Zhi X

Jul 8th, 2021 - Kallmann syndrome (KS) is a rare hereditary disease with high phenotypic and genetic heterogeneity. Congenital hypogonadotropic hypogonadism and hyposmia/anosmia are the two major characterized phenotypes of KS. Besides, mirror movements, dental a...

Gonadotropin Therapy Once a Week for Spermatogenesis in Hypogonadotropic Hypogonadism.
https://doi.org/10.1016/j.eprac.2021.04.009
Endocrine Practice : Official Journal of the American Col... Ma W, Mao J et. al.

Apr 30th, 2021 - Hypogonadotropic hypogonadism (HH) can be caused by congenital HH (CHH), pituitary stalk interruption syndrome (PSIS), and pituitary injury (acquired HH). Gonadotropin therapy, typically administrated every other day or twice a week, is a common m...

see more →

News  2 results

Replacement of Male Mini-Puberty
https://www.medscape.com/viewarticle/916021_2

Materials and Methods Patients Ten neonates and infants were included, all with bilateral cryptorchidism in the intra-abdominal or inguinal position and micropenis ≤2 cm (≤2 SDS).[14] The absence of neonatal male mini-puberty was confirmed with at...

Replacement of Male Mini-Puberty
https://www.staging.medscape.com/viewarticle/916021_2

Materials and Methods Patients Ten neonates and infants were included, all with bilateral cryptorchidism in the intra-abdominal or inguinal position and micropenis ≤2 cm (≤2 SDS).[14] The absence of neonatal male mini-puberty was confirmed with at...

see more →